Literature DB >> 15855337

Nonproteinuric diabetes-associated nephropathy in the Cohen rat model of type 2 diabetes.

Chana Yagil1, Adiel Barak, David Ben-Dor, Eliezer Rosenmann, Joel Bernheim, Mordechai Rosner, Yael Segev, Sarah Weksler-Zangen, Itamar Raz, Yoram Yagil.   

Abstract

The Cohen diabetic rat is an experimental model reminiscent of human type 2 diabetes. The aim of this study was to characterize the development of end-organ damage in this model. Cohen diabetic sensitive (CDs) and Cohen diabetic resistant (CDr) rats were fed regular diet or a diabetogenic diet. Glucose tolerance, renal function, and renal and retinal histology were studied at set intervals. CDs fed diabetogenic diet were the only strain that expressed the diabetic metabolic phenotype. In this strain, urinary protein excretion did not increase with the development of diabetes, but plasma urea and creatinine levels increased and creatinine clearance decreased. Light microscopy revealed in CDs enlarged glomeruli with increased mesangial matrix and thickening of the glomerular capillary wall; electron microscopy demonstrated thickened basement membrane and mesangial abundance. There was increased staining for type IV collagen in glomeruli and interstitium of CDs. The retinas of diabetic CDs demonstrated pathology consistent with nonproliferative diabetic retinopathy. The histological findings in the kidneys, the absence of proteinuria, the impairment in glomerular filtration, and the development of retinopathy in CDs are consistent with diabetes-associated nephropathy that is similar to a nonalbuminuric type of nephropathy associated with type 2 diabetes in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855337     DOI: 10.2337/diabetes.54.5.1487

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Authors:  Shaomin Shi; Lihua Ni; Ling Gao; Xiaoyan Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

Review 2.  Normoalbuminuric diabetic kidney disease.

Authors:  Chao Chen; Chang Wang; Chun Hu; Yachun Han; Li Zhao; Xuejing Zhu; Li Xiao; Lin Sun
Journal:  Front Med       Date:  2017-07-18       Impact factor: 4.592

Review 3.  Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives.

Authors:  Ankur Jindal; Mariana Garcia-Touza; Nidhi Jindal; Adam Whaley-Connell; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-08-01       Impact factor: 4.741

Review 4.  Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency.

Authors:  Miho Shimizu; Kengo Furuichi; Hitoshi Yokoyama; Tadashi Toyama; Yasunori Iwata; Norihiko Sakai; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2013-10-01       Impact factor: 2.801

5.  Psammomys obesus, a particularly important animal model for the study of the human diabetic nephropathy.

Authors:  Pnina Scherzer; Shachaf Katalan; Gay Got; Galina Pizov; Irene Londono; Anca Gal-Moscovici; Mordecai M Popovtzer; Ehud Ziv; Moise Bendayan
Journal:  Anat Cell Biol       Date:  2011-09-29

6.  Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function.

Authors:  Elif I Ekinci; George Jerums; Alison Skene; Paul Crammer; David Power; Karey Y Cheong; Sianna Panagiotopoulos; Karen McNeil; Scott T Baker; Paola Fioretto; Richard J Macisaac
Journal:  Diabetes Care       Date:  2013-07-08       Impact factor: 19.112

Review 7.  Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".

Authors:  Giuseppe Pugliese; Giuseppe Penno; Andrea Natali; Federica Barutta; Salvatore Di Paolo; Gianpaolo Reboldi; Loreto Gesualdo; Luca De Nicola
Journal:  J Nephrol       Date:  2020-02       Impact factor: 3.902

Review 8.  Update on pathogenesis and diagnosis flow of normoalbuminuric diabetes with renal insufficiency.

Authors:  Le Deng; Wenjie Li; Gaosi Xu
Journal:  Eur J Med Res       Date:  2021-12-11       Impact factor: 2.175

9.  Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy.

Authors:  Miho Shimizu; Kengo Furuichi; Tadashi Toyama; Shinji Kitajima; Akinori Hara; Kiyoki Kitagawa; Yasunori Iwata; Norihiko Sakai; Toshinari Takamura; Mitsuhiro Yoshimura; Hitoshi Yokoyama; Shuichi Kaneko; Takashi Wada
Journal:  Diabetes Care       Date:  2013-10-02       Impact factor: 19.112

10.  Administration of 3,5-diiodothyronine (3,5-T2) causes central hypothyroidism and stimulates thyroid-sensitive tissues.

Authors:  Alvaro Souto Padron; Ruy Andrade Louzada Neto; Thiago Urgal Pantaleão; Maria Carolina de Souza dos Santos; Renata Lopes Araujo; Bruno Moulin de Andrade; Monique da Silva Leandro; João Pedro Saar Werneck de Castro; Andrea Claudia Freitas Ferreira; Denise Pires de Carvalho
Journal:  J Endocrinol       Date:  2014-04-01       Impact factor: 4.286

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.